IL6 and hepatocellular carcinoma: One of the main mechanisms which can explain how inflammation leads to HCC is the activation of IL-6/Janus kinase 2 (Jak-2)/signal transducer and activator of transcription 3 (STAT3) signalling pathway, which is considered a potent promoting factor driving tumor formation in the liver14.